Catalog No.
RHK53203
Species reactivity
Human
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
ELISA: 1:10000, FCM: 1:200-1:400, IHC: 1:200-1:1000
Target
SATB2, DNA-binding protein SATB2, KIAA1034, Special AT-rich sequence-binding protein 2
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q9UPW6
Applications
ELISA, FCM, IHC
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R3Z09
SATB2 immunohistochemistry in osteosarcoma: Utility in diagnosis and differentiation from histologic mimics., PMID:40485468
Conventional (bone-type) giant cell tumor of the larynx: the first case with proven H3-3A: c.103G >T (p.Gly35Trp) mutation., PMID:39565412
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities., PMID:39377914
Special at-rich sequence-binding protein 2 and its role in healing of the experimental mandible bone tissue defect filling with a synthetic bone graft material and electrical stimulation impact., PMID:39360717
An extensive immunohistochemical analysis of 290 ovarian adult granulosa cell tumors with 29 markers., PMID:38904760
SATB2, CKAE1/AE3, and synaptophysin as a sensitive immunohistochemical panel for the detection of lymph node metastases of Merkel cell carcinoma., PMID:38066198
Wnt1 induces osteoblastic changes in a well-established osteolytic skeletal metastatic model derived from breast cancer., PMID:37840014
Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast Cancer., PMID:37306115
Chondroblastoma of foot bones; a clinicopathological study of 29 cases confirming the diagnostic utility of H3K36M and H3G34W antibodies at an uncommon site., PMID:37075609
Inhibition of RANKL Expression in Osteocyte-like Differentiated Tumor Cells in Giant Cell Tumor of Bone After Denosumab Treatment., PMID:36971322
Special AT-rich sequence-binding protein 2 (SATB2) in the differential diagnosis of osteogenic and non-osteogenic bone and soft tissue tumors., PMID:36128863
Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: a pathological, clinical and outcome study., PMID:34036629
Optimized Immunostaining of Embryonic and Early Postnatal Mouse Brain Sections., PMID:33732758
Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer., PMID:33632198
Identification of retinal ganglion cell types expressing the transcription factor Satb2 in three primate species., PMID:33527361
Intestinal, intestinal-type and intestine-localized metastatic adenocarcinoma. Immunohistochemical approach to the differential diagnosis., PMID:33336735
YJ5 as an immunohistochemical marker of osteogenic lineage., PMID:33187685
Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab: Support for Osteoblastic Differentiation., PMID:32773532
Histomorphometric Analysis of Pre- and Post-Denosumab-Treated Giant Cell Tumor of Bone., PMID:32429739
SRSF1-3, a splicing and somatic hypermutation regulator, controls transcription of IgV genes via chromatin regulators SATB2, UBN1 and histone variant H3.3., PMID:31986311
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations., PMID:31434953
Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas., PMID:30166615
Decrease of MiR-31 induced by TNF-α inhibitor activates SATB2/RUNX2 pathway and promotes osteogenic differentiation in ethanol-induced osteonecrosis., PMID:30132874
Histone H3K36M mutation and trimethylation patterns in chondroblastoma., PMID:30098026
EWSR1-SMAD3-rearranged Fibroblastic Tumor: An Emerging Entity in an Increasingly More Complex Group of Fibroblastic/Myofibroblastic Neoplasms., PMID:29957732
SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary., PMID:29924451
Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma., PMID:28438615
Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract Carcinosarcomas., PMID:28221217
The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas., PMID:27465835
BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities., PMID:27428733
The Role of SATB2 as a Diagnostic Marker of Sinonasal Intestinal-type Adenocarcinoma., PMID:27258560
Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series., PMID:26338802
SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors., PMID:26261600
Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry., PMID:25844674
Small cell osteosarcoma: clinicopathologic, immunohistochemical, and molecular analysis of 36 cases., PMID:25723116
Satb2-independent acquisition of the cholinergic sudomotor phenotype in rodents., PMID:25239161
Cerium promotes bone marrow stromal cells migration and osteogenic differentiation via Smad1/5/8 signaling pathway., PMID:25197425
Analysis of candidate genes for lineage-specific expression changes in humans and primates., PMID:24911366
[Clinicopathologic characteristics and histogenesis of mucinous tumor of peritoneum]., PMID:24842014
Overexpression of SATB1 is associated with biologic behavior in human renal cell carcinoma., PMID:24835085
The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study., PMID:24713733
The CB(1) cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis., PMID:23175820
Abnormal maturation and differentiation of neocortical neurons in epileptogenic cortical malformation: unique distribution of layer-specific marker cells of focal cortical dysplasia and hemimegalencephaly., PMID:22759905
Sonic hedgehog expression in corticofugal projection neurons directs cortical microcircuit formation., PMID:22445340
Scalable in situ hybridization on tissue arrays for validation of novel cancer and tissue-specific biomarkers., PMID:22412953
Generation of monospecific antibodies based on affinity capture of polyclonal antibodies., PMID:21898641
SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas., PMID:21677534
FIAT is co-expressed with its dimerization target ATF4 in early osteoblasts, but not in osteocytes., PMID:19232401
Epitope mapping of antibodies using bacterial surface display., PMID:19029907
SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression., PMID:14701874
For research use only. Not for human or drug use.
